Cargando…
Novel preclinical models of topical PrEP pharmacodynamics provide rationale for combination of drugs with complementary properties
BACKGROUND: The limited success of recent HIV topical pre-exposure prophylaxis clinical trials highlights the need for more predictive models of drug efficacy that better simulate what may happen during sexual exposure. To address this gap, we developed complementary in vitro models to evaluate the...
Autores principales: | Mesquita, Pedro MM, Srinivasan, Priya, Johnson, Todd J, Rastogi, Rachna, Evans-Strickfaden, Tammy, Kay, Michael S, Buckheit, Karen W, Buckheit Jr , Robert W, Smith, James M, Kiser, Patrick F, Herold, Betsy C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827994/ https://www.ncbi.nlm.nih.gov/pubmed/24156604 http://dx.doi.org/10.1186/1742-4690-10-113 |
Ejemplares similares
-
The importance of PrEP persistence in preventing HIV infections on PrEP
por: Spinelli, Matthew A, et al.
Publicado: (2020) -
“PrEP”ing for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women
por: Pasipanodya, Elizabeth C., et al.
Publicado: (2021) -
PrEP-RN: Clinical Considerations and Protocols for Nurse-Led PrEP
por: O'Byrne, Patrick, et al.
Publicado: (2019) -
1287. PrEP-Engaged or PrEP Curious?: A Characterization and Comparison of Initial PrEP Appointment Attenders vs. Nonattenders
por: Kahal, Deborah A, et al.
Publicado: (2019) -
Predictors of PrEP awareness, PrEP discussion and interest in long‐acting injectable PrEP among Filipina transfeminine adults
por: Restar, Arjee Javellana, et al.
Publicado: (2023)